TY - JOUR T1 - Successful treatment of antineutrophil cytoplasmic antibody-associated bronchiectasis with immunosuppressive therapy JF - European Respiratory Journal JO - Eur Respir J SP - 554 LP - 557 DO - 10.1183/09031936.00031115 VL - 46 IS - 2 AU - Raphael Lhote AU - Christine Theodore AU - Tasnime Issoufaly AU - Dominique Francois AU - Jean-Emmanuel Kahn AU - Loïc Guillevin AU - Elisabeth Rivaud AU - Camille Bron AU - Marc Vasse AU - Louis-Jean Couderc AU - Colas Tcherakian Y1 - 2015/08/01 UR - http://erj.ersjournals.com/content/46/2/554.abstract N2 - The underlying mechanisms of bronchiectasis are poorly understood and the cause remains unknown in half of the patients [1]. Whether bronchiectasis is the direct consequence of pathogen aggression or of an abnormal immune response remains unresolved [2–4]. We report here the first case of a patient with bronchiectasis improved by an immunosuppressive regimen.Could ANCA testing in bronchiectasis help to identify patients who would benefit from immunosuppressive regimens? http://ow.ly/L7Nat ER -